F
Francisco Velasco
Researcher at University of Seville
Publications - 80
Citations - 1590
Francisco Velasco is an academic researcher from University of Seville. The author has contributed to research in topics: Support vector machine & Data envelopment analysis. The author has an hindex of 20, co-authored 80 publications receiving 1374 citations. Previous affiliations of Francisco Velasco include ETSI & Venezuelan Institute for Scientific Research.
Papers
More filters
Journal ArticleDOI
Trip destination prediction based on past GPS log using a Hidden Markov Model
TL;DR: This approach drastically reduces the number of points supplied by the GPS device and it permits a ''support-map'' to be generated in which the main characteristics of the trips for each user are taken into account, which achieves total independence from a street-map database.
Journal ArticleDOI
Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome.
Pablo M. Dobado-Berrios,C. Lopez-Pedrera,Francisco Velasco,Maria Angeles Aguirre,Antoni Torres,Maria José Cuadrado +5 more
TL;DR: In this article, the authors analysed TF mRNA accumulation in freshly isolated mononuclear blood cells (MBC) of 14 patients with primary APS (PAPS) and six normal controls.
Journal ArticleDOI
Ameva: An autonomous discretization algorithm
TL;DR: A comparison between the Ameva and the genetic algorithm approaches has been realized and there are very small differences between these iterative and combinatorial approaches, except when considering the execution time.
Journal ArticleDOI
Municipal solid-waste recycling market and the European 2020 Horizon Strategy: A regional efficiency analysis in Spain
TL;DR: In this article, the analysis of the efficiency of Spanish regions in the development of the recycling market in their respective territories through the use of a novel Data Envelopment Analysis method with multiple outputs is presented.
Journal ArticleDOI
Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment.
Carlos Perez-Sanchez,Patricia Ruiz-Limon,Maria Angeles Aguirre,Maria Laura Bertolaccini,Munther A. Khamashta,Antonio Rodríguez-Ariza,P. Segui,Eduardo Collantes-Estevez,Nuria Barbarroja,Husam Khraiwesh,José A. González-Reyes,José M. Villalba,Francisco Velasco,Maria José Cuadrado,Chary López-Pedrera +14 more
TL;DR: The oxidative perturbation in APS patient leukocytes relies on alterations in mitochondrial dynamics and metabolism that may be prevented, reverted, or both by treatment with coenzyme Q(10) (CoQ(10).